European Heart Journal , 42 (48), 49054914
when it is personalized for a patient
PMID 32738473 Sikiric P, Rucman R, et al
The breadth of documented activity reflects what the original investigators have described as systems-level pharmacology: rather than acting through a single high-affinity receptor, BPC-157 appears to modulate multiple intersecting cellular pathways including nitric oxide signalling, growth-factor receptor expression, dopamine and serotonin metabolism, and angiogenic vessel formation
The content is solely the responsibility of the authors and does not necessarily represent the official views of the funding agencies
Relative mRNA levels of individual genes were reported as fold value of the control